Uveitis Treatment Global Market Report 2025

Description

Uveitis treatment involves medical measures designed to reduce inflammation inside the eye, helping to relieve symptoms and prevent vision loss. The treatment approach depends on the underlying cause and may include corticosteroids, immunosuppressive drugs, or antimicrobial medications. These treatments can be administered in various forms, such as eye drops, oral medications, injections, or implants, depending on the type and severity of the uveitis.

The primary indications for uveitis treatment include anterior uveitis, intermediate uveitis, posterior uveitis, and panuveitis. Anterior uveitis refers to inflammation of the front part of the uvea, primarily affecting the iris and ciliary body, often resulting in eye pain, redness, and vision changes. Treatment for uveitis can be categorized by the method of administration such as topical, systemic, or injectable therapies. These treatments address either infectious or non-infectious causes. Available therapeutic options include corticosteroids, immunosuppressants, monoclonal antibodies, cycloplegic agents, antibiotics, antivirals, antifungals, and analgesics. These treatments are available through various distribution channels, including hospital pharmacies, retail pharmacies, online pharmacies, and others.

The uveitis treatment market research report is one of a series of new reports from The Business Research Company that provides uveitis treatment market statistics, including the uveitis treatment industry global market size, regional shares, competitors with the uveitis treatment market share, detailed uveitis treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the uveitis treatment industry. This uveitis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The uveitis treatment market size has grown strongly in recent years. It will grow from $1.43 billion in 2024 to $1.54 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth during the historic period can be attributed to several factors, including the increased prevalence of autoimmune conditions, a growing geriatric population, a higher incidence of uveitis, enhanced awareness among healthcare professionals about the importance of early diagnosis and treatment, and a rising occurrence of infectious diseases.

The uveitis treatment market size is expected to see strong growth in the next few years. It will grow to 2.08 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth during the forecast period can be attributed to factors such as the increasing affordability of healthcare services, a rise in age-related eye disorders, a growing senior population, more research initiatives, and heightened awareness of eye health among the public. Key trends in the forecast period include the development of targeted therapies, advancements in laser surgery, innovative drug delivery systems, improvements in ophthalmology diagnostic tools, and a growing adoption of sustained-release drug delivery systems.

The growing prevalence of autoimmune conditions is expected to drive the expansion of the uveitis treatment market. Autoimmune conditions involve diseases in which the immune system attacks and damages the body's healthy cells, tissues, or organs. The rise in autoimmune diseases is influenced by factors such as genetic predisposition, environmental triggers, and lifestyle changes that affect the immune system. Uveitis treatment helps manage these conditions by reducing inflammation, controlling the immune system's overactivity, and preventing vision loss linked to autoimmune-related eye inflammation. For example, a 2022 report by the Germany-based healthcare data analytics company Versorgungsatlas revealed that, among 73,241,305 insured individuals, 6,304,340 were diagnosed with at least one autoimmune disease, leading to a prevalence rate of 8.61%. As a result, the increasing number of autoimmune cases is contributing to the growth of the uveitis treatment market.

Leading companies in the uveitis treatment market are focusing on creating innovative devices such as sustained-release intravitreal implants to improve patient adherence to treatment. These long-acting drug delivery systems are placed in the eye to ensure controlled and prolonged medication release. For instance, in February 2022, Alimera Sciences, a US-based biopharmaceutical company, launched ILUVIEN, a sustained-release intravitreal implant aimed at treating non-infectious posterior uveitis (NIPU) in Spain. The implant delivers fluocinolone acetonide directly into the eye, releasing the drug slowly for up to 36 months. This long-term treatment helps reduce inflammation and prevent relapses in recurrent NIPU. ILUVIEN is the first and only treatment of its kind for this condition, offering a more consistent and long-lasting effect while reducing the frequency of injections and improving patient outcomes.

In September 2024, ANI Pharmaceuticals, a US-based pharmaceutical company, acquired Alimera Sciences for an undisclosed sum. This acquisition aims to enhance ANI's Rare Disease division and broaden its presence in the ophthalmology market. Alimera Sciences specializes in the development and commercialization of ophthalmic pharmaceuticals, particularly those focused on retinal diseases such as uveitis.

Major players in the uveitis treatment market are Merck & Co. Inc., AbbVie Inc., Novartis AG, Regeneron Pharmaceuticals Inc., Kubota Vision Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Bausch & Lomb Incorporated, Horizon Therapeutics plc, Cipla Ltd., Santen Pharmaceutical Co. Ltd., Galapagos NV, ANI Pharmaceuticals Inc., EyePoint Pharmaceuticals Inc., Entod Pharmaceuticals Ltd., Sirion Therapeutics Inc., Kiora Pharmaceuticals Inc., Lux Biosciences Inc., Inflammasome Therapeutics Inc., and Clearside Biomedical Inc.

North America was the largest region in the uveitis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in uveitis treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the uveitis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The uveitis treatment market consists of sales of drugs, diagnostic tools, surgical equipment, intravitreal implants, and injections. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Uveitis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on uveitis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for uveitis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The uveitis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Indication: Anterior Uveitis; Intermediate Uveitis; Posterior Uveitis; Panuveitis
2) By Route Of Administration: Topical; Systemic; Injectable
3) By Cause: Infectious; Non-infectious
4) By Treatment: Corticosteroids; Immunosuppressant; Monoclonal Antibodies; Cycloplegic Agents; Antibiotics; Antivirals; Antifungal; Analgesics
5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
Subsegments:
1) By Anterior Uveitis: Infectious Anterior Uveitis; Non-Infectious Anterior Uveitis
2) By Intermediate Uveitis: Infectious Intermediate Uveitis; Non-Infectious Intermediate Uveitis
3) By Posterior Uveitis: Infectious Posterior Uveitis; Non-Infectious Posterior Uveitis
4) By Panuveitis: Infectious Panuveitis; Non-Infectious Panuveitis
Companies Mentioned: Merck & Co. Inc.; AbbVie Inc.; Novartis AG; Regeneron Pharmaceuticals Inc.; Kubota Vision Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r34179

1. Executive Summary

2. Uveitis Treatment Market Characteristics

3. Uveitis Treatment Market Trends And Strategies

4. Uveitis Treatment Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Uveitis Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Uveitis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Uveitis Treatment Market Growth Rate Analysis
5.4. Global Uveitis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Uveitis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Uveitis Treatment Total Addressable Market (TAM)

6. Uveitis Treatment Market Segmentation

6.1. Global Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Anterior Uveitis
Intermediate Uveitis
Posterior Uveitis
Panuveitis
6.2. Global Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Topical
Systemic
Injectable
6.3. Global Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Infectious
Non-infectious
6.4. Global Uveitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Corticosteroids
Immunosuppressant
Monoclonal Antibodies
Cycloplegic Agents
Antibiotics
Antivirals
Antifungal
Analgesics
6.5. Global Uveitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Other Distribution Channels
6.6. Global Uveitis Treatment Market, Sub-Segmentation Of Anterior Uveitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Infectious Anterior Uveitis
Non-Infectious Anterior Uveitis
6.7. Global Uveitis Treatment Market, Sub-Segmentation Of Intermediate Uveitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Infectious Intermediate Uveitis
Non-Infectious Intermediate Uveitis
6.8. Global Uveitis Treatment Market, Sub-Segmentation Of Posterior Uveitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Infectious Posterior Uveitis
Non-Infectious Posterior Uveitis
6.9. Global Uveitis Treatment Market, Sub-Segmentation Of Panuveitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Infectious Panuveitis
Non-Infectious Panuveitis

7. Uveitis Treatment Market Regional And Country Analysis

7.1. Global Uveitis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Uveitis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Uveitis Treatment Market

8.1. Asia-Pacific Uveitis Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Uveitis Treatment Market

9.1. China Uveitis Treatment Market Overview
9.2. China Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Uveitis Treatment Market

10.1. India Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Uveitis Treatment Market

11.1. Japan Uveitis Treatment Market Overview
11.2. Japan Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Uveitis Treatment Market

12.1. Australia Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Uveitis Treatment Market

13.1. Indonesia Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Uveitis Treatment Market

14.1. South Korea Uveitis Treatment Market Overview
14.2. South Korea Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Uveitis Treatment Market

15.1. Western Europe Uveitis Treatment Market Overview
15.2. Western Europe Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Uveitis Treatment Market

16.1. UK Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Uveitis Treatment Market

17.1. Germany Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Uveitis Treatment Market

18.1. France Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Uveitis Treatment Market

19.1. Italy Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Uveitis Treatment Market

20.1. Spain Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Uveitis Treatment Market

21.1. Eastern Europe Uveitis Treatment Market Overview
21.2. Eastern Europe Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Uveitis Treatment Market

22.1. Russia Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Uveitis Treatment Market

23.1. North America Uveitis Treatment Market Overview
23.2. North America Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Uveitis Treatment Market

24.1. USA Uveitis Treatment Market Overview
24.2. USA Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Uveitis Treatment Market

25.1. Canada Uveitis Treatment Market Overview
25.2. Canada Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Uveitis Treatment Market

26.1. South America Uveitis Treatment Market Overview
26.2. South America Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Uveitis Treatment Market

27.1. Brazil Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Uveitis Treatment Market

28.1. Middle East Uveitis Treatment Market Overview
28.2. Middle East Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Uveitis Treatment Market

29.1. Africa Uveitis Treatment Market Overview
29.2. Africa Uveitis Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Uveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Uveitis Treatment Market, Segmentation By Cause, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Uveitis Treatment Market Competitive Landscape And Company Profiles

30.1. Uveitis Treatment Market Competitive Landscape
30.2. Uveitis Treatment Market Company Profiles
- 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Kubota Vision Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Uveitis Treatment Market Other Major And Innovative Companies

31.1. UCB S.A.
31.2. Sun Pharmaceutical Industries Ltd.
31.3. Bausch & Lomb Incorporated
31.4. Horizon Therapeutics plc
31.5. Cipla Ltd.
31.6. Santen Pharmaceutical Co. Ltd.
31.7. Galapagos NV
31.8. ANI Pharmaceuticals Inc.
31.9. EyePoint Pharmaceuticals Inc.
31.10. Entod Pharmaceuticals Ltd.
31.11. Sirion Therapeutics Inc.
31.12. Kiora Pharmaceuticals Inc.
31.13. Lux Biosciences Inc.
31.14. Inflammasome Therapeutics Inc.
31.15. Clearside Biomedical Inc.

32. Global Uveitis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Uveitis Treatment Market

34. Recent Developments In The Uveitis Treatment Market

35. Uveitis Treatment Market High Potential Countries, Segments and Strategies

35.1 Uveitis Treatment Market In 2029 - Countries Offering Most New Opportunities
35.2 Uveitis Treatment Market In 2029 - Segments Offering Most New Opportunities
35.3 Uveitis Treatment Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer